Edition:
United States

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

4.83USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$4.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
632,634
52-wk High
$7.66
52-wk Low
$4.31

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 21 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.62 1.62 1.62

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 5.83 9.80 3.78 20.40
Quarter Ending Mar-19 2 8.99 9.19 8.80 --
Year Ending Dec-18 7 17.05 20.70 14.79 38.78
Year Ending Dec-19 7 107.28 180.20 66.46 211.77
Earnings (per share)
Quarter Ending Dec-18 7 -0.17 -0.13 -0.22 -0.10
Quarter Ending Mar-19 3 -0.14 -0.11 -0.16 --
Year Ending Dec-18 7 -0.59 -0.54 -0.64 -0.43
Year Ending Dec-19 7 -0.36 -0.12 -0.60 0.11

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 4.43 3.47 0.96 21.64
Quarter Ending Jun-18 4.25 3.76 0.48 11.39
Quarter Ending Mar-18 4.19 3.77 0.41 9.87
Quarter Ending Dec-17 4.66 4.12 0.54 11.53
Quarter Ending Sep-17 5.22 4.42 0.80 15.35
Earnings (per share)
Quarter Ending Sep-18 -0.21 -0.16 0.05 -24.42
Quarter Ending Jun-18 -0.12 -0.15 0.03 -26.48
Quarter Ending Mar-18 -0.10 -0.11 0.01 -14.94
Quarter Ending Dec-17 -0.09 -0.10 0.02 -17.65
Quarter Ending Sep-17 -0.11 -0.07 0.04 -35.66

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5.83 5.83 6.43 6.43 20.40
Quarter Ending Mar-19 8.99 8.99 7.61 7.61 --
Year Ending Dec-18 17.05 17.05 18.62 18.67 38.78
Year Ending Dec-19 107.28 107.28 112.27 112.27 211.77
Earnings (per share)
Quarter Ending Dec-18 -0.17 -0.17 -0.17 -0.17 -0.10
Quarter Ending Mar-19 -0.14 -0.14 -0.16 -0.16 --
Year Ending Dec-18 -0.59 -0.59 -0.62 -0.62 -0.43
Year Ending Dec-19 -0.36 -0.36 -0.34 -0.34 0.11

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 2 4
Quarter Ending Mar-19 0 0 1 0
Year Ending Dec-18 0 0 0 5
Year Ending Dec-19 0 0 1 4
Earnings
Quarter Ending Dec-18 0 0 3 1
Quarter Ending Mar-19 0 0 1 0
Year Ending Dec-18 0 0 4 2
Year Ending Dec-19 0 0 3 3